Development of arrestin-biased dopamine D1 receptor (D1R) ligand for the treatment of Parkinson's disease with minimal L-DOPA induced dyskinesia
Administered By
Awarded By
Contributors
- Barak, Lawrence Simeon Principal Investigator
- Wetsel, William Christopher Co Investigator
Start/End
- February 1, 2023 - July 31, 2024